Gita Thanarajasingam, MD

  • 297 Citations
  • 10 Scopus h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gita Thanarajasingam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hand Sanitizers Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 297 Citations
  • 10 Scopus h-Index
  • 19 Article
  • 5 Letter
  • 3 Review article

Assessment of Adverse Events from the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial

Dueck, A. C., Scher, H. I., Bennett, A. V., Mazza, G. L., Thanarajasingam, G., Schwab, G., Weitzman, A. L., Rogak, L. J. & Basch, E., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Clinical Trials
Self Report

Impact of lymphoma survivorship clinic visit on patient-centered outcomes

Viscuse, P., Yost, K. J., Jenkins, S., Lackore, K., Habermann, T. M., Thanarajasingam, G. & Thompson, C. A., Jan 1 2019, In : Journal of Cancer Survivorship.

Research output: Contribution to journalArticle

Ambulatory Care
Survival Rate
17 Citations (Scopus)

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

Thanarajasingam, G., Minasian, L. M., Baron, F., Cavalli, F., De Claro, R. A., Dueck, A., El-Galaly, T. C., Everest, N., Geissler, J., Gisselbrecht, C., Gribben, J., Horowitz, M., Ivy, S. P., Jacobson, C. A., Keating, A., Kluetz, P. G., Krauss, A., Kwong, Y. L., Little, R. F., Mahon, F. X. & 20 others, Matasar, M. J., Mateos, M. V., McCullough, K., Miller, R. S., Mohty, M., Moreau, P., Morton, L. M., Nagai, S., Rule, S., Sloan, J. A., Sonneveld, P., Thompson, C. A., Tzogani, K., van Leeuwen, F. E., Velikova, G., Villa, D., Wingard, J. R., Wintrich, S., Seymour, J. F. & Habermann, T. M., Jan 1 2018, (Accepted/In press) In : The Lancet Haematology.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Needs Assessment
Stem Cell Transplantation
B-Cell Lymphoma
14 Citations (Scopus)

Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop

Kluetz, P. G., Kanapuru, B., Lemery, S., Johnson, L. L., Fiero, M. H., Arscott, K., Barbachano, Y., Basch, E., Campbell, M., Cappelleri, J. C., Cella, D., Cleeland, C., Coens, C., Daniels, S., Denlinger, C. S., Fairclough, D. L., Hillard, J. R., Minasian, L., Mitchell, S. A., O'Connor, D. & 8 others, Patel, S., Rubin, E. H., Ryden, A., Soltys, K., Sridhara, R., Thanarajasingam, G., Velikova, G. & Coons, S. J., Jun 1 2018, In : Value in Health. 21, 6, p. 742-747 6 p.

Research output: Contribution to journalArticle

Critical Pathways
United States Food and Drug Administration
Lymphoma, Large B-Cell, Diffuse
Omega-3 Fatty Acids
Disease-Free Survival